Ray Manneh Kopp

12PUBLICATIONS
97CO-AUTHORS
Molecular targetsEnglish languageCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 16, 2026
CABOPRE: Evaluating Perioperative Cabozantinib's Efficacy and Biomarkers for Cytoreductive Nephrectomy in Advanced Renal Cell Carcinoma.

|Jul 22, 2026
Structural Inequities in Global Oncology: Latin America and Caribbean Representation at the ASCO Genitourinary Cancers Symposium (2021-2025).

|Jan 12, 2026
A REtrospective Study to Describe the Real-World Treatment Landscape in Patients with Metastatic Castration-Resistant PROstate Cancer: REMPRO.

Ray Manneh, Tarek Hashem, Joung Jae Young

|Oct 29, 2025
Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study.

Francesco Massari, Matteo Rosellini, Bohuslav Melichar

|Mar 05, 2025
Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial.

Daniel P Petrylak, Raffaele Ratta, Nobuaki Matsubara

|Sep 30, 2024
Genomic Landscape in Prostate Cancer in a Latin American Population.

Martín Angel, Berenice Freile, Andres Rodriguez

Pageof 2

Frequent Collaborators

3 joint publications

Maria Teresa Bourlon

3 joint publications

Fernando Sabino Marques Monteiro

3 joint publications

Andrey Soares

3 joint publications

Martín Angel